GetPortalImpactFactorByIdResp(projectId=1, id=c6435998, cover=https://img.medsci.cn/images/journal/cover/2021/UAF_202109271316306670.jpg, fullname=REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, abbr=REV ENDOCR METAB DIS, pyear=2000, frequence=Quarterly, articleNumbers=555, citedSelf2015=3.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均6月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1389-9155, greenSci=https://www.greensci.net/search?kw=1389-9155, scijournal=https://www.scijournal.org/impact-factor-of-REV-ENDOCR-METAB-DIS.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.747, medsciHotlight=1.566, medsciHotlight5year=2.52093, citescore=0.0, hIndex=77, impactFactor=8.2, orgnization=Springer Netherlands, orgnizationUrl=http://springerlink.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.springer.com/medicine/internal/journal/11154, websiteHits=4569, guideForAuthor=null, guideForAuthorHits=13, submitWebsite=https://www.editorialmanager.com/remd/default.aspx, submitWebsiteHits=1486, content=<p>Reviews in Endocrine and Metabolic Disorders is be an international journal dedicated to students clinicians and researchers involved in the broad area of endocrinology and metabolism. This field of medicine and biology is rapidly advancing and a major challenge is to keep abreast of the advances in the field. The mission of this review journal is to keep those interested individuals informed of all the latest exciting advancements that are essential to their research or clinical practice. The format of this review journal differs from existing journals. Each of the quarterly issues covers a specific topic. Ten to twelve articles will be published by world leaders in this area. The individual papers are brief overviews of the latest developments with insight into the basic aspects of the disease and translation into clinical aspects. Thus the student academic clinician and practicing clinician will be able to understand the disease process and apply this knowledge to his or her area of interest. Selected readings and other essential references will enable the reader to investigate a particular topic in a more in-depth approach.</p>, totalCites=4552, brief=REV ENDOCR METAB DIS杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=内分泌学与代谢" >内分泌学与代谢</a></strong>”子行业的中等级别杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=REV ENDOCR METAB DIS在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=c6435998'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=716, tagName=代谢, createdHits=3), ImpactFactorTagDto(id=122141, tagName=内分泌遗传代谢, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.04), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.24), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.75), GetImpactFactorCiteScoreListResponse(year=2019, citescore=11.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.82), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.055), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.211), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.458), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.747)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Endocrinology, Diabetes and Metabolism , rank=12/211), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Endocrinology , rank=9/118)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1389-9155[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=REVIEWS IN ENDOCRINE & METABOLIC DISORDERS[ta], article_number=90, article_number_cn=6, earlyWarning=不在预警名单中, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)